Brainstorm Cell Therapeutics Inc.
BCLI
$1.00
$0.011.01%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -97.33% | -99.09% | -84.49% | -97.02% | -76.25% |
| Total Receivables | 52.83% | 82.09% | 36.51% | 100.00% | 221.21% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -77.44% | -92.43% | 42.22% | 171.15% | 86.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -79.14% | -92.11% | -20.26% | 39.56% | -60.30% |
|
|
|||||
| Total Current Assets | -79.14% | -92.11% | -20.26% | 39.56% | -60.30% |
| Net Property, Plant & Equipment | -68.77% | -65.70% | -64.30% | -57.68% | -50.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.89% | 5.88% | 32.04% | 25.62% | 13.07% |
| Total Assets | -69.29% | -78.86% | -44.21% | -31.85% | -54.85% |
|
|
|||||
| Total Accounts Payable | 24.86% | 7.65% | 16.23% | 39.47% | 12.30% |
| Total Accrued Expenses | 23.71% | -23.05% | -36.03% | -59.54% | -48.89% |
| Short-term Debt | 1,148.51% | 10.75% | 222.33% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -70.34% | -64.11% | -62.11% | -51.58% | -32.69% |
| Total Finance Division Other Current Liabilities | 82.46% | 32.35% | 65.66% | 79.69% | 57.64% |
| Total Other Current Liabilities | 82.46% | 32.35% | 65.66% | 79.69% | 57.64% |
| Total Current Liabilities | 45.23% | 7.92% | 22.60% | 27.41% | 10.88% |
|
|
|||||
| Total Current Liabilities | 45.23% | 7.92% | 22.60% | 27.41% | 10.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1,148.51% | 10.75% | 222.33% | -- | -- |
| Capital Leases | -- | -- | -- | -81.55% | -76.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 43.63% | 6.67% | 14.70% | 12.26% | -6.37% |
|
|
|||||
| Common Stock & APIC | 2.20% | 2.71% | 3.69% | 4.23% | 4.10% |
| Retained Earnings | -4.53% | -4.17% | -4.55% | -4.85% | -5.18% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -91.46% | -47.63% | -28.61% | -27.01% | -71.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -91.46% | -47.63% | -28.61% | -27.01% | -71.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -91.46% | -47.63% | -28.61% | -27.01% | -71.73% |
|
|
|||||